HomeCompareRAFX vs JNJ

RAFX vs JNJ: Dividend Comparison 2026

RAFX yields 200.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RAFX wins by $119.34M in total portfolio value
10 years
RAFX
RAFX
● Live price
200.00%
Share price
$1.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$119.36M
Annual income
$60,176,096.29
Full RAFX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — RAFX vs JNJ

📍 RAFX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRAFXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RAFX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RAFX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RAFX
Annual income on $10K today (after 15% tax)
$17,000.00/yr
After 10yr DRIP, annual income (after tax)
$51,149,681.85/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, RAFX beats the other by $51,148,978.23/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RAFX + JNJ for your $10,000?

RAFX: 50%JNJ: 50%
100% JNJ50/50100% RAFX
Portfolio after 10yr
$59.69M
Annual income
$30,088,462.03/yr
Blended yield
50.41%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

RAFX
No analyst data
Altman Z
58.5
Piotroski
0/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RAFX buys
0
JNJ buys
0
No recent congressional trades found for RAFX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRAFXJNJ
Forward yield200.00%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$119.36M$20.0K
Annual income after 10y$60,176,096.29$827.78
Total dividends collected$112.49M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RAFX vs JNJ ($10,000, DRIP)

YearRAFX PortfolioRAFX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$30,700$20,000.00$10,676$355.77+$20.0KRAFX
2$90,232$57,383.18$11,407$389.39+$78.8KRAFX
3$254,173$157,624.56$12,198$426.53+$242.0KRAFX
4$686,927$414,961.74$13,056$467.62+$673.9KRAFX
5$1,783,118$1,048,106.39$13,987$513.12+$1.77MRAFX
6$4,450,613$2,542,677.12$14,998$563.56+$4.44MRAFX
7$10,693,420$5,931,263.38$16,098$619.52+$10.68MRAFX
8$24,760,608$13,318,648.86$17,295$681.69+$24.74MRAFX
9$55,315,649$28,821,798.66$18,599$750.82+$55.30MRAFX
10$119,363,841$60,176,096.29$20,022$827.78+$119.34MRAFX

RAFX vs JNJ: Complete Analysis 2026

RAFXStock

Rafex Gold Corp., a development stage company, focuses on operating in the natural resource industry in Russia. The company intends to acquire a gold mine in the North Baikal region of Buryatia that covers an area of approximately 20 square kilometers. It would also engage in the forestry operations in Buryatia by providing round timber and sawn wood. The company was formerly known as Sakha Enterprises Corporation and changed its name to Rafex Gold Corp. in September 2022. Rafex Gold Corp. was incorporated in 2000 and is headquartered in Toronto, Canada.

Full RAFX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this RAFX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RAFX vs SCHDRAFX vs JEPIRAFX vs ORAFX vs KORAFX vs MAINRAFX vs ABBVRAFX vs MRKRAFX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.